BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in ACET — Adicet Bio, Inc.

CIK 1107261 HOUSTON, TX

Position in ACET

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$742,685

+$268,218 QoQ

Shares Held

85,959

+52.5% QoQ

Ownership

0.918%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#17

of 56 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. ACET ranks #25 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$742,685	85,959	+52.5%	Shares	Sole	2026-08-14
2025-12-31	$474,467	56,350	-93.8%	Shares	Sole	2026-02-17
2025-09-30	$730,296	901,600	0.0%	Shares	Sole	2025-11-14
2025-06-30	$549,976	901,600	0.0%	Shares	Sole	2025-08-14
2025-03-31	$680,708	901,600	-12.2%	Shares	Sole	2025-05-15
2024-12-31	$987,589	1,026,600	+20.5%	Shares	Sole	2025-02-14
2024-09-30	$1,226,304	851,600	+345.2%	Shares	Sole	2024-11-14
2024-06-30	$231,473	191,300	+47.4%	Shares	Sole	2024-08-14
2024-03-31	$305,030	129,800	+136.9%	Shares	Sole	2024-05-15
2023-12-31	$103,572	54,800	-78.0%	Shares	Sole	2024-02-14
2023-09-30	$341,404	249,200	+1146.1%	Shares	Sole	2023-11-14
2021-06-30	$205,789	19,999	-17.6%	Shares	Sole	2021-08-16
2021-03-31	$317,634	24,284	0.0%	Shares	Sole	2021-05-17
2020-12-31	$341,190	24,284	-0.0%	Shares	Sole	2021-02-16
2020-09-30	$288,760	24,286	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.